Salem, NH, February 27, 2009 --(PR.com
)-- Quantification of Vitamin D is becoming ever more important as researchers link this omnipotent molecule to more and more disease states. A steroid hormone traditionally regarded within the context of the intestinal absorption of calcium and the regulation of calcium homeostasis, Vitamin D in the clinical setting has been measured as a monitor of the demineralization of bone. In recent times, Vitamin D deficiencies have been implicated in other, acute metabolic conditions including a strong link to the risk for heart disease (Wang, et al., Circulation. 2008 Jan 29; 117 (4): 503-11 ).
Serum measurements of 25-OH vitamin D by ELISA are easy and cost-effective for laboratories without access to the gold standard method, LC-MS/MS. The 25-OH vitamin D ELISA kit offered by ALPCO is highly sensitive and specific for vitamin D2 (67%) and D3 (100%), thanks to both a novel monoclonal antibody and an effective sample pre-treatment procedure in which vitamin D is released from its’ binding protein, VDBP. This ELISA is for research use only, and not intended for in vitro diagnostic use. The sensitivity and specificity of the ALPCO kit offers an excellent correlation to the gold standard LC-MS/MS method, as well as HPLC, RIA, and other ELISA methods. Improving on earlier methods, the new 25-OH vitamin D ELISA offers industry-leading ease-of-use features, with minimum hands-on time and a convenient overnight incubation step. This ELISA fits into your daily work-flow, not the other way around.
ALPCO is focused on the immunoassay systems we manufacture and distribute. Our primary goal is to offer unique, diversified immunoassay solutions for our customers involved in basic science and pre-clinical research. We are scientists committed to supporting scientists.